Management of Dermatological Adverse Reactions in Patients Undergoing Antineoplastic Chemotherapy

June 2023 in “ Revista de Ciências Médicas e Biológicas ”

JANE BEATRIZ LIMBERGER, C. Schäfer

alopecia antineoplastic chemotherapy skin discoloration hyperpigmentation photosensitivity erythema peeling itching

Studysummary This study examined current literature and recommendations for preventing and treating skin lesions induced by chemotherapy, highlighting common dermatological issues such as discoloration, pruritus, and alopecia, and noting that specific treatments can alleviate these problems to improve patients' skin integrity, self-esteem, and quality of life.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The study reviews current recommendations for managing dermatological adverse reactions in patients undergoing antineoplastic chemotherapy. It highlights that common skin-related issues include discoloration, hyperpigmentation, photosensitivity, erythema, peeling, and itching, along with hair and nail changes such as alopecia. Effective management of these side effects can improve skin integrity and enhance patients' self-esteem and quality of life.

View this study on periodicos.ufba.br →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Dermatologic Adverse Events from Cancer Treatments

2 citations , October 2018 in “Springer eBooks”

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Clinical Management of Cutaneous Adverse Events in Patients on Targeted Anticancer Therapies and Immunotherapies: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

research Clinical Management of Cutaneous Adverse Events in Patients on Targeted Anticancer Therapies and Immunotherapies: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

26 citations , October 2018 in “Clinical & Translational Oncology”

This review outlines dermatological toxicities associated with targeted cancer therapies and immunotherapies, emphasizing the need for collaborative management by oncologists and dermatologists but reports no new clinical findings.

research JAK Inhibitors in Dermatology: The Promise of a New Drug Class

355 citations , January 2017 in “Journal of the American Academy of Dermatology”

This review reports no new results and highlights existing research suggesting JAK inhibitors may be effective in treating inflammatory skin conditions like alopecia areata, atopic dermatitis, psoriasis, and vitiligo.

research Cutaneous Adverse Effects of Targeted Therapies

192 citations , January 2015 in “Journal of the American Academy of Dermatology”

This review discusses skin-related toxicities associated with targeted cancer therapies and emphasizes the need for dermatologists to understand and manage these adverse effects, but reports no new experimental results.